Slingsby J H, Baban D, Sutton J, Esapa M, Price T, Kingsman S M, Kingsman A J, Slade A
Oxford BioMedica (UK) Ltd, Medawar Centre.
Hum Gene Ther. 2000 Jul 1;11(10):1439-51. doi: 10.1089/10430340050057512.
A number of stable producer cell lines for high-titer Mo-MuLV vectors have been constructed. Development has previously centered on increasing end-point titers by producing maximal levels of Mo-MuLV Gag/Pol, envelope glycoproteins, and retroviral RNA genomes. We describe the production yields and transduction efficiency characteristics of two Mo-MuLV packaging cell lines, FLYA13 and TEFLYA. Although they both produce 4070A-pseudotyped retroviral vectors reproducibly at >1 x 10(6) LFU ml(-1), the transduction efficiency of unconcentrated and concentrated virus from FLYA13 lines is poor compared with vector preparations from TEFLYA lines. A powerful inhibitor of retroviral transduction is secreted by FLYA13 packaging cells. We show that the inhibitory factor does not affect transduction of target cells by RD114-pseudotyped vectors. This suggests that the inhibitory factor functions at the level of envelope-receptor interactions. Phosphate starvation of target cells shows a two-fold increase in Pit2 receptor mRNA and causes some improvement in FLYA13 virus transduction efficiency. Western blots show that FLYA13 viral samples contain an eight-fold higher ratio of 4070A envelope to p30gag than that of virus produced by TEFLYA producer cell lines. This study correlates overexpression of 4070A envelope glycoprotein in retroviral preparations with a reduction of transduction efficiency at high multiplicities of infection. We suggest that TEFLYA packaging cells express preferable levels of 4070A compared with FLYA13, which not only enables high-titer stocks to be generated, but also facilitates a high efficiency of transduction of target cells.
已经构建了许多用于高滴度莫洛尼氏鼠白血病病毒(Mo-MuLV)载体的稳定生产细胞系。此前的研究主要集中在通过产生最大水平的Mo-MuLV Gag/Pol、包膜糖蛋白和逆转录病毒RNA基因组来提高终点滴度。我们描述了两种Mo-MuLV包装细胞系FLYA13和TEFLYA的生产产量和转导效率特征。尽管它们都能以大于1×10⁶ 感染性单位/毫升(LFU/ml⁻¹)的产量可重复地产生4070A假型逆转录病毒载体,但与来自TEFLYA细胞系的载体制剂相比,FLYA13细胞系未浓缩和浓缩病毒的转导效率较低。FLYA13包装细胞分泌一种强大的逆转录病毒转导抑制剂。我们表明,该抑制因子不影响RD114假型载体对靶细胞的转导。这表明该抑制因子在包膜-受体相互作用水平发挥作用。靶细胞的磷酸盐饥饿显示Pit2受体mRNA增加两倍,并使FLYA13病毒的转导效率有所提高。蛋白质免疫印迹显示,FLYA13病毒样本中4070A包膜与p30gag的比例比TEFLYA生产细胞系产生的病毒高八倍。本研究将逆转录病毒制剂中4070A包膜糖蛋白的过表达与高感染复数下转导效率的降低相关联。我们认为,与FLYA13相比,TEFLYA包装细胞表达的4070A水平更合适,这不仅能够产生高滴度的病毒储备,还有助于高效转导靶细胞。